The role of renin–angiotensin system inhibition in the treatment of hypertension in metabolic syndrome: are all the angiotensin receptor blockers equal?

Author: Karagiannis Asterios   Mikhailidis Dimitri P   Athyros Vasilios G   Kakafika Anna I   Tziomalos Konstantinos   Liberopoulos Evangelos N   Florentin Matilda   Elisaf Moses  

Publisher: Informa Healthcare

ISSN: 1472-8222

Source: Expert Opinion on Therapeutic Targets, Vol.11, Iss.2, 2007-02, pp. : 191-205

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content